Key result
SF-6Dv2 captures health differences more sensitively than EQ-5D-5L in dialysis patients despite moderate agreement.
Why the study?
Measuring HRQoL in dialysis patients is essential, but evidence comparing updated instruments in Chinese dialysis patients remains limited.
Does the SF-6Dv2 instrument perform differently than the EQ-5D-5L in measuring health-related quality of life in Chinese dialysis patients?
Cross-Sectional (n=378)
Yes
Does the SF-6Dv2 instrument perform differently than the EQ-5D-5L in measuring health-related quality of life in Chinese dialysis patients?
The SF-6Dv2 instrument is more sensitive than the EQ-5D-5L in capturing health state differences among Chinese dialysis patients, indicating the two scales cannot be used interchangeably.
Answers are grounded in this paper and cite their sources.
EQ-5D-5L and SF-6Dv2 should not be interchanged in Chinese dialysis patients; leaves open optimal HRQoL instrument selection.
BACKGROUND: Measuring health-related quality of life (HRQoL) in dialysis patients is essential for clinical assessment and economic evaluation. Despite the emergence and increasing use of updated instruments, evidence comparing their performance in Chinese dialysis patients remains limited. The aim of this study was to compare the measurement properties of the EQ-5D-5L and the SF-6Dv2 instruments in Chinese patients on dialysis and to provide a reference for future utility scale choice for Chinese dialysis patients. METHODS: Data were obtained using Wen Juan Xing questionnaire from dialysis patients during November 2023 to January 2024 in hospitals in China. The questionnaire included the EQ-5D-5L, SF-6Dv2, the kidney disease quality of life instrument (KDQOL-36), clinical and socio-demographic characteristics. The agreement of utility scores was assessed using intra class correlation coefficients (ICC) and Bland-Altman plots. The construct validity was evaluated using Spearman's correlation coefficient. The known group validity was evaluated by comparing the scores among patients with different health states, and sensitivity was compared using relative efficiency and the effect size. RESULTS: A total of 378 patients (male, 49.5%; mean age, 49.1 years) were included in this study. The ICC between EQ-5D-5L and SF-6Dv2 utility values was 0.639. The correlation between the two scales was strong (0.767). Both scales showed known groups validity, although the SF-6Dv2 was more sensitive. The differences in the SF-6Dv2 scores for patients in better and worse health state were greater than those measured by the EQ-5D-5L scores. CONCLUSIONS: Both EQ-5D-5L and SF-6Dv2 instruments are valid for dialysis patients. However, the two scales cannot be used interchangeably, and it appears that the SF-6Dv2 was more sensitive in capturing health state differences for dialysis patients in China.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a cross-sectional in End-stage renal disease on dialysis (n=378). EQ-5D-5L vs. SF-6Dv2 was evaluated on Agreement between EQ-5D-5L and SF-6Dv2 utility scores (ICC 0.639, p=<0.001). The EQ-5D-5L and SF-6Dv2 instruments demonstrated moderate agreement in Chinese dialysis patients, with the SF-6Dv2 being more sensitive in capturing health state differences.
Synapse has enriched 10 related papers. Consider them for comparative context: